Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Feb 07, 2005
HEMISPHERX BIOPHARMA EXPANDS EVALUATION OF ALFERON N AGAINST AVIAN FLU
Jan 03, 2005
HEMISPHERX BIOPHARMA INITIATES ENROLLMENT IN HIV/HEP-C CLINICAL PROGRAM
Dec 27, 2004
HEMISPHERX BIOPHARMA FILES LAWSUIT IN FEDERAL COURT ALLEGING CONSPIRACY BY FOREIGN NATIONALS TO MANIPULATE ITS STOCK PRICE AND ENGAGE IN ILLEGAL HOSTILE TAKEOVER
Dec 21, 2004
Los Angeles Times Article Focuses on Hemispherx Biopharma's Experimental Drug Ampligen as a Potential New Therapy for Chronic Fatigue Syndrome
Nov 22, 2004
HEMISPHERX BIOPHARMA INITIATES ALFERON LDO® CLINICAL PROGRAM IN COLLABORATION WITH PRINCESS MARGARET HOSPITAL IN HONG KONG
Nov 12, 2004
HEMISPHERX BIOPHARMA THIRD QUARTER 2004 EARNINGS ANNOUNCED
Nov 08, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE
Nov 01, 2004
Hemispherx Biopharma Presented New Data at the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, D.C.
Oct 25, 2004
HEMISPHERX BIOPHARMA TO PRESENT AT THE RODMAN & RENSHAW TECHVEST 6TH ANNUAL HEALTHCARE CONFERENCE ON OCTOBER 27th
Oct 20, 2004
Unexpected Neurological Damage Spreads with West Nile Virus; Heightens Concern in Healthcare Community
57
58
59
60
61
62
63
64
65
66
67
<<
<
>
>>
Privacy